연구성과로 돌아가기

2021 연구자 정보 (170 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Andersen, Katie
(Andersen, K)
Vaccitech, Oxford, England

[JCR상위 5.9] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1/MVA THERAPEUTIC VACCINATION COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN WELL-CONTROLLED CHB SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
Barnard, Abbey
(Barnard, A)
Univ Calif San Diego, Dept Med, Div Gastroenterol, ACTRI Bldg,1W202,9452 Med Ctr Dr, La Jolla, CA 92037 USA

[JCR상위 5.9] Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY roloomba@ucsd.edu;
Barnes, Eleanor
(Barnes, E)
Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England

[JCR상위 5.9] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1/MVA THERAPEUTIC VACCINATION COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN WELL-CONTROLLED CHB SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
Brown, Anthony
(Brown, A)
Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England

[JCR상위 5.9] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1/MVA THERAPEUTIC VACCINATION COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN WELL-CONTROLLED CHB SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
Bussey, Louise
(Bussey, L)
Vaccitech, Clin Operat, Oxford, England

[JCR상위 5.9] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1/MVA THERAPEUTIC VACCINATION COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN WELL-CONTROLLED CHB SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
Chen, Chi-Yi
(Chen, CY)
Chia Yi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan

[JCR상위 5.9] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1/MVA THERAPEUTIC VACCINATION COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN WELL-CONTROLLED CHB SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
Choi, Yura
(Choi, Y)
Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Daegu, South Korea

[JCR상위 5.9] CIRCULAR NONCODING RNA HSACIRC₀₀₀₅₉₈₆ AS A PROGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
Chon, Young Eun
(Chon, YE)
CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Pocheon Si, South Korea
CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Seongnam, South Korea


[JCR상위 5.9] AN EXTERNAL VALIDATION OF FIBROSCAN-AST SCORE (FAST) FOR NON-INVASIVE IDENTIFICATION OF PATIENTS AT RISK OF PROGRESSIVE NON-ALCOHOLIC STEATOHEPATITIS
[JCR상위 48.0] Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
MEDICINE, GENERAL & INTERNAL
dh.sinn@samsung.com;ksukorea@yuhs.ac;
Chuang, Wan-Long
(Chuang, WL)
Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan C-9536-2009
Chuang, Wan-Long
0000-0002-2376-421X
Chuang, Wan-Long
[JCR상위 5.9] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1/MVA THERAPEUTIC VACCINATION COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN WELL-CONTROLLED CHB SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
Cusi, Kenneth
(Cusi, K)
Univ Florida, Gainesville, FL 32611 USA
Univ Florida, Gainesville, FL USA
ADV-2401-2022
Cusi, Kenneth

[JCR상위 5.9] ARO-HSD, AN INVESTIGATIONAL RNAi THERAPEUTIC, DEMONSTRATES REDUCTION IN ALT AND HEPATIC HSD17B13 mRNA AND PROTEIN IN PATIENTS WITH NASH OR SUSPECTED NASH
[JCR상위 4.8] ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH
SCIE 4.8 GASTROENTEROLOGY & HEPATOLOGY jhamilton@arrowheadpharma.com;
Dalekos, George N.
(Dalekos, GN)
Univ Thessaly, Dept Med & Res, Lab Internal Med, Volos, Greece

[JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
Dave, Shravan
(Dave, S)
제1저자 Univ Calif San Diego, Dept Med, Div Gastroenterol, ACTRI Bldg,1W202,9452 Med Ctr Dr, La Jolla, CA 92037 USA

[JCR상위 5.9] Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY roloomba@ucsd.edu;
Do, Huiwon
(Do, H)
Kyungpook Natl Univ, Dept Adv Integrat Sci & Technol, Daegu, South Korea

[JCR상위 5.9] CIRCULAR NONCODING RNA HSACIRC₀₀₀₅₉₈₆ AS A PROGNOSTIC BIOMARKER FOR HEPATOCELLULAR CARCINOMA SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
Eagling-Vose, Elizabeth
(Eagling-Vose, E)
Vaccitech, Clin Operat, Oxford, England

[JCR상위 5.9] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1/MVA THERAPEUTIC VACCINATION COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN WELL-CONTROLLED CHB SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
Evans, Thomas
(Evans, T)
제1저자 Vaccitech, Adm, Oxford, England

[JCR상위 5.9] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1/MVA THERAPEUTIC VACCINATION COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN WELL-CONTROLLED CHB SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY
페이지 이동: